ABSTRACT Galactosylated BSA (gaIBSA) and its conjugate to horseradish peroxidase (gaIBSA-HRP) enter the galactose-specific pathway of hepatocytes . 10 min after intravenous injection, structures containing either ligand sediment mostly between 33,000 and 3 x 106 g~min (LP fraction) and have an equilibrium density of 1 .11-1 .13 g/ml in sucrose gradients (Quintart, J., P. J . Courtoy, J . N . Limet, and P. Baudhuin, 1983, Eur . J. Biochem ., 131 :105-112) .
succinate dehydrogenase using tetrazolium cytochemistry (8) . In comparison, the DAB-induced density shift takes advantage of a highly sensitive, exogenous enzyme, that can be introduced into specific organelles along the endocytic pathway by fluid-phase or receptor-mediated endocytosis (7, 23, 27, 29, 33) . In addition, this procedure is simple, fairly reproducible, and proved useful to analyze and to purify ligand-HRP-containing organelles (24) . This work has already been presented in abstract form (5) .
MATERIALS AND METHODS
Preparation of Ligand and Ligand-HRP Conjugates: Galactosylated BSA (gaIBSA) was prepared according to Wilson (38) , using a 96-h incubation in a 0.1 M borate buffer at pH 9 . It was radiolabeled by reductive methylation (21), using ["C]formaldehyde (The Radiochemical Centre, Amersham Corp., UK). Unlabeled gaIBSA was conjugated to HRP (type VI, Sigma Chemical Co., St. Louis, MO) after Nakane and Kawaoi (22) and labeled with sodium ['H]borohydride (Amersham Corp.) . The conjugate (gaIBSA-HRP) was cleared of unconjugated HRP and gal BSA, as well as of large polymer; or aggregates, by isokinetic centrifugation in a sucrose gradient (17) .
Characterization of Ligand-HRP Conjugates: The HRP/ gaIBSA molar ratio, determined from the absorbance at 280 and 403 nm, was 1 .4 and l .7 for the two preparations used in this study. Ligand concentration was measured after Lowry et al. (20) , using BSA as standard. The HRP activity of the conjugate was assayed using N,N-dimethyl-p-phenylenediamine (Merck, Darmstadt, Federal Republic of Germany) according to Straus (30) or DAB in a gelatin medium, as described by Herzog and Fahimi (16) . This activity corresponded to 240-400 Wg HRP (type VI)/mg gaIBSA. Radioactivity was measured in a Beckman LS 7500 DPM liquid scintillation counter (Beckman Instruments, Palo Alto, CA), after dissolution of the sample in 10 ml Aqualuma cocktail (Lumac Systems, Basel, Switzerland).
Ga1BSA-HRP conjugate, like gaIBSA, was recognized almost exclusively by the galactose-specific receptor of the hepatocytes since : (a) after intravenous injection to rats, the conjugate was rapidly cleared from the blood by the liver, (b) after cytothemistry, gaIBSA-HRP was found almost exclusively in the hepatocytes by light and electron microscopy, and (c) the uptake of ga1BSA-HRP by cultured rat hepatocytes could be inhibited by a large excess of asialofetuin or gaIBSA, but not by native BSA . In addition, the subcellular distribution of both ligands after dif%rential and isopycnic centrifugations was comparable, indicating similar processing by the cell (23).
Preparation ofDAB Solutions: 3,3'-Diaminobenzidinetetrahydrochloride (type II, lot 88C-03201, Sigma Chemical Co .) was dissolved at a concentration of 2 .56 mg/ml (7 .1 mM) in 0 .74 M sucrose (density: 1 .1 g/ml), buffered with 3 mM imidazole/HCl (31) and the pH was carefully adjusted to 7 .0 with concentrated NaOH. This brownish solution was cleared by filtration on two layers of a 0.2-gym pore MetricelA filter (Gelman, Ann Arbor, MI) and used extemporaneously. The absorbance at 280 nm of the filtrate diluted 50 . fold was 1 .63 t 0 .06. The stability of DAB solutions in the presence of HzOz was routinely checked before use. Solutions that rapidly turned brown were discarded . Subcellular Fractionation : Rats (200-25o g) were injected intravenously with I kg/g body wt fH]gaIBSA-HRP (126 nCi/wg) or ["C]gaIBSA (7 nCi/pg) . 10 min after injection, the liver was perfused by the portal vein with H l6 tissue culture medium (Gibco Biocult, Paisley, UK). The liver homogenate was fractionated by dif%rential centrifugation (9) to successively pellet N (10,000 g~min), M (33,000 g~min), and combined LP (3 x 106 g~min) fractions . z LP fractions (Sml) were layered on the top of a 32-m1 linear sucrose gradient (from 1 .1 to 1 .3 g/ml in density), buffered with 3 mM imidazole/HCI, pH 7 .0. After centrifugation for 24 x 106 g~min in a VTi 50 rotor (Beckman Instruments), l4 fractions were collected and analyzed as previously described (23) . The two fractions containing the highest radioactivity (average density : I .12 g/ml) were pooled and will be further referred to as LP, pool.
For the diaminobenzidine procedure, 1 .75 ml of the LP, pool was added to 6 .25 ml of the DAB solution (final concentration : 5.5 mM, nominal) . The reaction was started by the addition of 50~1 of 6% HZ Oz, prepared extemporaneously by dilution of a 30% H20z stock solution in sucrose-imidazole, and performed for 30 min at 25°C, in the dark, under gentle agitation . The H,Oz concentration in the incubation medium ( l I mM) was measured by the TiOSOe z See Materials and Methods of the companion paper (24) for an explanation of the fraction nomenclature . colorimetric assay (4) . The stock HZ Oz concentration was verified by KMnO, titration (32) .
After incubation, 5 ml of the suspension was equilibrated in a second linear sucrose gradient (density, 1 .13-1 .30 g/ml) . Fractions therefrom were analyzed for density, radioactivity, and enzyme activities . Owing to an interference of DAB with the protein assay of Lowry et al. (20) , liver protein was labeled in some experiments by a pulse of ['°C]leucine (125~Ci) injected intraperitoneally 40 h before sacrifice. In such conditions, values of 3 .6 ± 0 .7 nCi/mg liver protein and 431 ± 3 nCi/ml plasma were obtained (n = 3).
EIeCtron MiCrOSCOpy: The subcellular fractions were fixed by the slow addition of glutaraldehyde (7 .5% in 0.1 M cacodylate, pH 7 .4) to a final concentration of 1 .5% ( l8) and kept overnight at 4°C . About 100~g of protein of each fraction of interest was then applied over a I-cmz MilliporeR filter, 50-nm nominal pore size (Millipore Corp ., Bedford, MA), and filtered under one to two bars (2) . The retention of the material on the filter was ascertained by measuring the radioactivity of the filtrate and was >90% . The pellicle was post6xed for I h at 4°C in a solution containing 1 % osmium tetroxide and l potassium ferrocyanide and dehydraded in graded alcohol . After dissolution of the nitrocellulose filter in propylene oxide, the pellicle was embedded in the mixture described by Spurr (26) . Ultrathin sections were examined unstained under 60 kV in a EM 301 Philips electron microscope . (23) . For DAB cytochemistry, the LP, pool corresponding to the peak of the [3H]-ga1BSA-HRP distribution (density, 1.11-1 .13 g/ml) was incubated at 25°C in buffered sucrose (density, 1 .1 g/ml), containing 5.5 mM DAB and 11 mM HZOz. This resulted in the development ofa brownish color. In the absence of HZOZ, the mixture remained yellowish. After 30 min incubation, the granules were equilibrated again in a sucrose gradient.
RESULTS

Effect
IfHZOz was included in the incubation medium, the density distribution of [3H]ga1BSA-HRP shifted towards a heavier density, upon equilibration in a second sucrose gradient ( labeled protein remained in the low density region, although a minor component shifted towards a heavier density, probably representing protein associated with ligand-containing structures. If HzOz was omitted, the distributions of [ 3 H ]-ga1BSA-HRP-and ['°C]leucine-labeled protein remained at low density . In this case, distributions were only slightly shifted 00.01 g/ml in density) in comparison to fractions incubated without DAB .
Origin and Factors of the DAB-induced
If ga1BSA-HRP was replaced by ga1BSA, or if either DAB or Hz02 was omitted from the incubation medium, no significant change in the color or the distribution of the ligand was observed. Therefore, the major shift of the equilibrium density of ligand-HRP conjugates after incubation in DAB and HZOz stems from the oxidation of DAB by HRP . These experiments also indicate that no significant endogenous HZOZ or peroxidatic activity was present in the low density fractions .
The relation between the association of oxidized-polymerized DAB to the granules and the density shift was further studied. First, the density distribution of oxidized DAB after cytochemistry was compared with that of gaIBSA-HRP . For this purpose, LP, pools were prepared from rats injected with either gaIBSA-HRP or ga1BSA . After incubation in presence of DAB and HzOs, the preparations were equilibrated in a O/ 2 THE JOURNAL OF CELL BIOLOGY " VOLUME 9S, 1984 second sucrose gradient and the absorbance at 465 nm was measured. The difference in the absorbance of corresponding fractions was taken as an estimate of HRP-oxidized DAB. As can be seen in Fig. 3 , the distributions of oxidized DAB and gaIBSA-HRP were very similar. Next, DAB was oxidized and polymerized with ferricyanide (13) or by soluble HRP and HZ OZ and then layered on the top of a sucrose gradient. After centrifugation, all brown material was found as a pellet below the heavy sucrose cushion (density, 1 .34 g/ml) . This demonstrates that the equilibrium density of oxidized and polymerized DAB is > 1.34 g/ml and that accumulation of this compound inside vesicles should result in a substantial increase oftheir equilibrium density.
Changing parameters of the DAB reaction was shown to influence the extent of the density shift. Reduction of the amount of ga1BSA-HRP injected, of incubation time, or of DAB concentration all resulted in a smaller density shift of the ga1BSA-HRP distribution (Fig. 4) . In our standard conditions (5 .5 mM DAB), the DAB concentration was not largely decreased at the end of the incubation, as measured by performing the gelatin assay (16) in the presence of a constant HRP concentration . In the same conditions, HZOz concentration rapidly dropped, with a half-life of~10 min. However, repeated addition of HzOz during the incubation did not enhance the density shift . We also tested if the onestep addition of HZOz could be replaced to advantage by a continuous production of HzOz, using a glucose/glucose oxidase system . A similar DAB-induced density shift could be produced but the procedure was less reproducible.
Finally, to assess the accessibility of DAB into membraneclosed organelles, LP, pools from rats injected with gaIBSA-HRP were assayed for HRP activity, in a medium containing 0.74 M sucrose, 3 mM imidazole/HCI, pH 7.0, 5.5 mM DAB, 11 mM HZOz, and 0.1 % gelatin, in the presence or absence of 0.1 % Triton X-100. While Triton X-100 had no significant effect on the activity offree HRP, its addition to the organelle suspension caused a 10-fold increase of the HRP activity. In our opinion, these observations most likely reflect a restriction in the diffusion of soluble DAB through intact biological membranes, although an inhibition of HRP by the reaction product trapped inside the particles could also explain our results.
Specificity of the DAB-induced Density Shift
To assess the specificity ofthe density shift, in vitro mixing experiments were performed . A rat was injected with pools were isolated as previously described . First, they were incubated separately in DAB and HZOz and equilibrated again in a sucrose gradient. As in the previous experiments, the distribution of gaIBSA-HRP was shifted to a higher density and that of gaIBSA was not appreciably affected. Next, the LP, pools from the two animals were mixed in vitro, incubated together in DAB and HZOz, and equilibrated again in a sucrose gradient. The distribution of [3H]gaIBSA-HRP was shifted and that of ['°C]gaIBSA remained essentially unchanged (Fig. 5 ). This demonstrates that the DAB-induced density shift is specific to HRP-containing organelles and that no appreciable agglutination, or fusion between similar organelles, occurred in our experimental conditions . Therefore, the DAB-induced density shift can be used to demonstrate the dissociation of two similar and yet distinct subcellular populations . By contrast, if free HRP (1 wg/ml) was added to the LP, pool from a rat injected with gaIBSA and incubated with DAB and HzOz, DAB was immediately oxidized and the radioactivity was recovered with DAB as a pellet, below a density of 1 .34 g/ml. This indicates that free HRP caused the agglutination ofparticles and that the specificity ofthe DAB-induced density shift may be jeopardized in the presence of soluble HRP and possibly of other heme proteins.
Concomitant Density Shift of Two Ligands
A rat received a simultaneous injection of [3H]ga1BSA-HRP and ['4C]ga1BSA. An LP fraction was first equilibrated in a sucrose gradient. The density distribution ofboth ligands was similar and displayed a peak in the low density region. The LP, pool was incubated in DAB and HZOz and equilibrated again in a sucrose gradient. The density distributions of gaIBSA-HRP and gaIBSA shifted concomitantly (Fig. 6) . Other structures remained essentially at the initial low density, as indicated by the distributions of marker enzymes for the plasma membrane, lysosomes, and the Golgi complex (not shown) . The density distributions of these marker enzymes are presented in detail in the companion paper (24) . Since the density shift induced by ga1BSA-HRP ("active" ligand) caused a concomitant density shift of ga1BSA ("passive" ligand), but not of other components, this experiment demonstrated that both derivatives were localized within the 874 THE IOURNAL OE CELL BIOLOGY " VOLUME 9S, 1984 same organelles. This result illustrates that the DAB shift procedure could be used to test directly whether components with overlapping distributions in a fractionation system are truly associated to the same host particles, provided agglutination of granules can be excluded (see Discussion).
Electron Microscopy
After the DAB-induced density shift, the material recovered at the density of 1 .23 g/ml was fixed, processed for electron microscopy without further incubation in DAB and HzOZ, and examined unstained (Fig. 7) . For comparison, LP, pools were first fixed and then incubated in DAB and HZOz. In both preparations, ligand-containing structures were identified as vesicles and tubules filled with electron dense material. However, application of the cytochemical procedure of Graham and Karnovsky (12) to unfixed organelles resulted in a lower contrast than with fixed specimens (see Fig. 7 of reference 23 for comparison). This is attributed to the restricted diffusion of soluble DAB through intact membranes, as previously discussed. Whereas DAB-stained structures represented a small proportion of the organelles occurring in the LP, pool (not shown), they constituted a major component (45-53% of the total volume of particles) of the high density fractions, after the DAB-induced density shift.
DISCUSSION Physical Basis of the Density Shift
Several lines of evidence indicate that the shift in the equilibrium density of HRP-containing organelles results from the trapping ofDAB that has been oxidized and polymerized inside these organelles by HRP: (a) the density shift requires the simultaneous presence ofHRP, DAB, and HzOz, and increases as a function of HRP and DAB concentrations ; (b) the density distribution of ligand-HRP conjugate after cytochemistry was similar to that of HRP-oxidized DAB ; (c) as observed by electron microscopy, a large proportion ofthe structures equilibrating at higher density after cytochemistry were filled with DAB reaction product; and (d) the equilibrium density of polymerized DAB is > 1 .34 g/ml.
Our interpretation ofthe physical basis ofthe DAB-induced density shift is outlined in Fig. 8 . The model accounts for the major increase in density of HRP-containing organelles, and for the specificity of the density shift, which is restricted to HRP-containing structures. Although our results imply that DAB gains access inside unfixed closed structures, the latency ofHRP towards DAB in preparations ofintact granules points to a restriction of the diffusion of DAB through biological membranes. This is not surprising in view of the polar character ofthe DAB molecule, and explains most probably that the concentration (5.5 mM) required for obtaining a large density shift is 10-fold the optimal concentration of the assay for free HRP (16) .
Validity of the Method
In our hands, the DAB-induced density shift appeared as a fairly simple, reproducible, and specific procedure . The specificity ofthe density shift to ligand-HRP containing structures was demonstrated by in vitro mixing experiments, a criterion already used by Leskes et al. (19) . In addition, only a minor portion of the protein shifted after cytochemistry, and the distribution of several marker enzymes present in the initial preparation was largely unaffected (24) .
However, the specificity of the procedure can be jeopardized. The preparation should be virtually free of soluble, and possibly externally exposed or adsorbed, HRP activity. As mentioned in Results, free HRP rapidly oxidized DAB outside the organelles, leading to agglutination of the preparation . This is an important caveat, since it may preclude the use of the method in preparations containing soluble HRP or soluble HRP conjugates. In addition, the possibility of obtaining a specific density shift when HRP is associated to open structures, such as membrane fragments, is not yet documented. Furthermore, subcellular fractions of different purity, composition, or origin may exhibit specific agglutinating properties or contain various amounts ofendogenous H202 or HRP activity. As a consequence, it should be stressed that while a dissociation in the distributions of different markers demonstrated by the DAB shift procedure may be considered as conclusive, the evidence ofthe association oftwo components based on the criterion of concomitant DAB-induced density shift requires that agglutination can be excluded, for example by in vitro mixing experiments.
Analytical and Preparative Applications to Subcellular Organelles
Most purification procedures based on specific density alterations induce a primary change in the density of specific organelles, resulting from the in vivo accumulation of light (11, 35, 36) or heavy material (15). In contrast, the density alteration described in this and other (8, 19, 25) papers is performed in vitro on subcellular organelles whose equilibrium density is initially unaffected.
Since DAB cytochemistry induces a shift towards heavier densities, this procedure is particularly suited for the purification of organelles equilibrating at a low density. Indeed, a two-step purification protocol can be followed in this case. A first density equilibration can be used to clear the preparation from organelles equilibrating in the heavy region of the gradient. After DAB cytochemistry is performed on the particles equilibrating at low density, a second isopycnic centrifugation will place HRP-containing particles at their new (heavier) equilibrium density, in a region of the gradient devoid of other particles . Particles without HRP will remain at their initial density. Application of this strategy to the purification of the low density ligand-containing structures is reported in the companion paper (24) .
Examination of the results reported here shows that the shifted distributions of HRP-containing structures are more disperse than the initial ones. This may affect the yield of a purification. Assuming a Poisson distribution for the exogenous marker molecules throughout a population of vesicles, considerable variation may occur in the marker content of individual vesicles, if the average number of molecules per vesicle is small. For example, ifan average of 10 molecules of HRP-conjugate have been introduced per low density vesicle, the standard deviation will be 3.2 molecules per vesicle . Such variation in the content of "active" ligand may account for the observed dispersion in the distribution of ga1BSA-HRPcontaining vesicles, after DAB cytochemistry .
Our procedure can also be applied for analytical purposes, in the same way as density shifts induced by other compounds, such as digitonin or pyrophosphate (1) . In the companion paper, we report the application of DAB-induced density shift to the analysis of highly purified ligand-containing structures, using gaIBSA-HRP (24) . The same procedure was also applicable to the study of the lysosomal membrane of fibroblasts after HRP uptake by fluid-phase endocytosis and accumulation in lysosomes (10) . Finally, we have also applied the procedure of the DAB-induced density shift to the study of ligand sorting in rat hepatocytes. Polymeric immunoglobulin A, a ligand that is transferred into bile and ga1BSA-HRP, which is digested in lysosomes, were injected simultaneously at various times before sacrifice . The concomitant shift of polymeric immunoglobulin A ("passive" ligand) and ga1BSA-HRP ("active" ligand) was used to assess their association to the same structure (6) .
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